These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8655279)

  • 1. [How can improved effectiveness of the loop diuretic furosemide be explained when the same dosage is administered 2 x daily (morning and noon)?].
    Steffgen J
    Internist (Berl); 1996 Apr; 37(4):400-1. PubMed ID: 8655279
    [No Abstract]   [Full Text] [Related]  

  • 2. Furosemide pharmacokinetics and pharmacodynamics following gastroretentive dosage form administration to healthy volunteers.
    Klausner EA; Lavy E; Stepensky D; Cserepes E; Barta M; Friedman M; Hoffman A
    J Clin Pharmacol; 2003 Jul; 43(7):711-20. PubMed ID: 12856384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NXY-059 does not significantly interact with furosemide in healthy volunteers.
    Strid S; Nilsson D; Borgå O; Wemer J; Grahnén A
    J Clin Pharmacol; 2006 Dec; 46(12):1417-25. PubMed ID: 17101741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Features of the pharmacodynamics and pharmacokinetics of furosemide upon long-term administration in rats].
    Briukhanov VM; Zverev IaF; Lampatov VV; Zharikov AIu
    Eksp Klin Farmakol; 2007; 70(2):33-6. PubMed ID: 17523448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacodynamics of piretanide in compromised kidney function. Dose response relationship and equipotency with furosemide].
    Keller E; Reetze-Bonorden P; Rambauseck M; Pooth R
    Internist (Berl); 1992 Aug; 33 Suppl 1():S36-8. PubMed ID: 1428696
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of plasma protein binding on renal metabolism and dynamics of furosemide in the rabbit.
    Pichette V; Geadah D; du Souich P
    Drug Metab Dispos; 1999 Jan; 27(1):81-5. PubMed ID: 9884313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inclusion complexation of furosemide in cyclodextrins. Part 2: Implication on bioavailability.
    Ammar HO; Ghorab M; Emara LH; el-Nahhas SA; Makram TS
    Pharmazie; 1999 Mar; 54(3):207-10. PubMed ID: 10192107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion.
    Dormans TP; van Meyel JJ; Gerlag PG; Tan Y; Russel FG; Smits P
    J Am Coll Cardiol; 1996 Aug; 28(2):376-82. PubMed ID: 8800113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of bioequivalence of two furosemide preparations; the effect of high doses of furosemide on some pharmacokinetic parameters.
    Wolf-Coporda A; Lovrić Z; Huić M; Francetić I; Vrhovac B; Plavsić F; Skreblin M
    Int J Clin Pharmacol Res; 1996; 16(4-5):83-8. PubMed ID: 9172005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced absorption of oral furosemide by bile juice in rats.
    Kim EJ; Han KS; Lee MG
    Res Commun Mol Pathol Pharmacol; 1999; 104(1):107-10. PubMed ID: 10604283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-dosing metolazone with loop diuretic combination regimens.
    Lorenz RA; Elwell RJ
    Nephrol Nurs J; 2006; 33(1):78-9. PubMed ID: 16538931
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanism of ascorbic acid enhancement of the bioavailability and diuretic effect of furosemide.
    Lee MG; Chiou WL
    Drug Metab Dispos; 1998 May; 26(5):401-7. PubMed ID: 9571221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection, quantification, and pharmacokinetics of furosemide and its effects on urinary specific gravity following IV administration to horses.
    Dirikolu L; Lehner AF; Hughes C; Karpiesiuk W; Camargo FC; Harkins JD; Woods WE; Bosken JM; Boyles J; Troppmann A; Fisher M; Tobin T
    Vet Ther; 2003; 4(4):350-63. PubMed ID: 15136977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of submaximal exercise on the pharmacokinetics of furosemide in horses.
    Dyke TM; Hinchcliff KW; Sams RA; McKeever KH; Muir WW
    J Vet Pharmacol Ther; 1996 Apr; 19(2):164-6. PubMed ID: 8735429
    [No Abstract]   [Full Text] [Related]  

  • 15. Depletion of residues of furosemide, a loop diuretic, in lactating dairy cows.
    Shaikh B; O'Driscoll JL; Cullison R
    J Vet Pharmacol Ther; 2002 Oct; 25(5):387-8. PubMed ID: 12423231
    [No Abstract]   [Full Text] [Related]  

  • 16. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma pharmacokinetics of intravenous and intramuscular furosemide in the camel (Camelus dromedarius).
    Ali BH; Wong YC; Alhadrami GA; Charles BG; Bashir AK
    Res Vet Sci; 1998; 64(1):69-72. PubMed ID: 9557809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cytochrome P450 inducers and inhibitors on the pharmacokinetics of intravenous furosemide in rats: involvement of CYP2C11, 2E1, 3A1 and 3A2 in furosemide metabolism.
    Yang KH; Choi YH; Lee U; Lee JH; Lee MG
    J Pharm Pharmacol; 2009 Jan; 61(1):47-54. PubMed ID: 19126296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Emax model in diuretic studies.
    Noormohamed FH
    Br J Clin Pharmacol; 1990 Dec; 30(6):907-8. PubMed ID: 2288838
    [No Abstract]   [Full Text] [Related]  

  • 20. The pharmacokinetics of furosemide in anaesthetized horses after bilateral ureteral ligation.
    Dyke TM; Hubbell JA; Grosenbaugh DA; Beard W; Mitten L; Sams RA; Hinchcliff KW
    J Vet Pharmacol Ther; 1998 Aug; 21(4):298-303. PubMed ID: 9731952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.